瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010 
瑞普生物(300119) 利润表
单位:万元
报表日期2020-09-302020-06-302020-03-312019-12-312019-09-30
一、营业总收入146,131.7092,432.8245,392.20146,658.05103,312.25
营业收入146,131.7092,432.8245,392.20146,658.05103,312.25
二、营业总成本112,565.5372,237.7935,681.82125,580.6785,268.34
营业成本63,851.7040,275.9919,536.8969,915.8749,886.39
营业税金及附加1,260.12868.97382.231,782.371,245.99
销售费用26,991.1017,528.538,949.3827,944.3117,265.05
管理费用11,035.977,547.724,113.3914,135.288,727.67
财务费用2,136.641,573.96827.482,323.601,588.75
研发费用7,290.004,442.611,872.439,479.246,554.51
资产减值损失----------
公允价值变动收益1,493.551,170.94620.526,821.76--
投资收益-3.1330.678.261,502.451,558.89
其中:对联营企业和合营企业的投资收益-38.4016.440.06-139.57-55.69
汇兑收益----------
三、营业利润33,386.3819,978.289,914.0326,306.7420,013.28
加:营业外收入70.9840.288.68191.87135.24
减:营业外支出214.2995.0978.90506.9795.09
其中:非流动资产处置损失----------
四、利润总额33,243.0719,923.479,843.8125,991.6420,053.42
减:所得税费用4,612.632,984.891,375.523,611.772,760.07
五、净利润28,630.4416,938.578,468.2822,379.8617,293.35
归属于母公司所有者的净利润25,226.8514,729.727,312.8619,435.9914,465.32
少数股东损益3,403.602,208.861,155.422,943.872,828.04
六、每股收益
基本每股收益(元/股)0.63760.37290.18520.48940.3636
稀释每股收益(元/股)0.63760.37290.18520.48940.3636
七、其他综合收益----------
八、综合收益总额28,630.4416,938.578,468.2822,379.8617,293.35
归属于母公司所有者的综合收益总额25,226.8514,729.727,312.8619,435.9914,465.32
归属于少数股东的综合收益总额3,403.602,208.861,155.422,943.872,828.04
下载全部历史数据到excel中 返回页顶